Abnormally High Levels of Virus-Infected IFN-γ+CCR4+CD4+CD25+ T Cells in a Retrovirus-Associated Neuroinflammatory Disorder
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Human T-lymphotropic virus type 1 (HTLV-1) is a human retrovirus associated with both HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), which is a chronic neuroinflammatory disease, and adult T-cell leukemia (ATL). The pathogenesis of HAM/TSP is known to be as follows: HTLV-1-infected T cells trigger a hyperimmune response leading to neuroinflammation. However, the HTLV-1-infected T cell subset that plays a major role in the accelerated immune response has not yet been identified. PRINCIPAL FINDINGS: Here, we demonstrate that CD4(+)CD25(+)CCR4(+) T cells are the predominant viral reservoir, and their levels are increased in HAM/TSP patients. While CCR4 is known to be selectively expressed on T helper type 2 (Th2), Th17, and regulatory T (Treg) cells in healthy individuals, we demonstrate that IFN-gamma production is extraordinarily increased and IL-4, IL-10, IL-17, and Foxp3 expression is decreased in the CD4(+)CD25(+)CCR4(+) T cells of HAM/TSP patients as compared to those in healthy individuals, and the alteration in function is specific to this cell subtype. Notably, the frequency of IFN-gamma-producing CD4(+)CD25(+)CCR4(+)Foxp3(-) T cells is dramatically increased in HAM/TSP patients, and this was found to be correlated with disease activity and severity. CONCLUSIONS: We have defined a unique T cell subset--IFN-gamma(+)CCR4(+)CD4(+)CD25(+) T cells--that is abnormally increased and functionally altered in this retrovirus-associated inflammatory disorder of the central nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mogamulizumab targets CCR4, a chemokine receptor highly expressed by HTLV-1-infected T cells [198,199,200], with phase I and II clinical trials resulting in an overall response rate (ORR) of 50% [201,202,203].”
From Current State of Therapeutics for HTLV-1 (2024) · cites this paper as [200]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS
Gessain, A., Vernant, J. C., Maurs, L., Barin, F., Gout, O., Calender, A., & De Thé, G. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92734-5 · Cited by 2,843
HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITY
Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, M., & Tara, M. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91298-5 · Cited by 2,404
Adult T-cell leukemia: clinical and hematologic features of 16 cases
Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., & Uchino, H. (1977) · Blood · doi:10.1182/blood.v50.3.481.481 · Cited by 2,316
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856 · cited 1×
“Previous studies have observed significant reductions in Foxp3 expression and/or Treg function in several human autoimmune diseases, including multiple sclerosis (MS), myasthenia gravis, and type I diabetes [17,19], suggesting that defects in Foxp3 expression and/or Treg function may precipitate the loss of immunologi…”
ResultSurface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828 · cited 3×
“More recently, it has been observed that CCR4 is expressed on Th17 cells [23].”
BackgroundShimoyama, M., & members of The Lymphoma Study Group (1984–87) (1991) · British Journal of Haematology · doi:10.1111/j.1365-2141.1991.tb08051.x · Cited by 1,608 · cited 1×
“HAM/TSP was diagnosed according to the guidelines defined by the WHO, and ATL was diagnosed on the basis of the criteria proposed by Shimoyama [46].”
MethodFoxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
Sakaguchi, S., Ono, M., Setoguchi, R., Yagi, H., Hori, S., Fehervari, Z., Shimizu, J., Takahashi, T., & Nomura, T. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00427.x · Cited by 1,555 · cited 4×
“Although Treg cells are phenotypically similar to activated T cells, they can be identified ex vivo by the intracellular expression of the transcriptional regulator Foxp3 [18], which is critical for the development and function of Treg cells in both mice and humans [17].”
BackgroundResultInfluentialFOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,189 · cited 1×
“The high Foxp3 expression without cytokine production and low Foxp3 expression with cytokine production in CD4CD25CCR4 T cells (Figure 3A) are consistent with recent reports demonstrating that Foxp3 can target and repress the transcriptional activity of NFAT-AP-1 complexes present at the cytokine promoter [43].”
Result
Cited by
Yamano, Y., & Sato, T. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00389 · Cited by 204
Self-citationInflammatory manifestations of HTLV-1 and their therapeutic options
Martin, F., Taylor, G. P., & Jacobson, S. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.966690 · Cited by 147
“Although short-term (up to 12 months) treatment with HTLV-1 reverse transcriptase inhibitors did not reduce pVL, the identification of CCR4 expression as a marker of infected cells [218,219] offers new hope for a treatment to reduce the viral burden and thus the inflammatory response.”
BackgroundSelf-citationThe role of viral infections in the development of autoimmune diseases
Hussein, H. M., & Rahal, E. A. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2019.1614904 · Cited by 154
“…Treg-defining transcription factor forkhead box P3 (FOXP3) gene was low in these subjects consequently resulting in decreased levels of anti-inflammatory cytokines produced by Tregs such as IL-10 and TGF-b (Brito-Melo et al. 2007; Toulza et al. 2008; Yamano et al. 2009; Satou and Matsuoka 2010).”
BackgroundInfluentialHTLV-1 modulates the frequency and phenotype of FoxP3+CD4+T cells in virus-infected individuals
Satou, Y., Utsunomiya, A., Tanabe, J., Nakagawa, M., Nosaka, K., & Matsuoka, M. (2012) · Retrovirology · doi:10.1186/1742-4690-9-46 · Cited by 130
“Furthermore, FoxP3 CD4 T cells in HAM/TSP patient contain an increased FoxP3 non-Treg population (Figure 5F), which would contribute to the inflammatory phenotype of HAM/TSP via generation of pro-inflammatory cytokine-producing CD4 T cells such as THAM cells [46] or exFoxp3 cells [47].”
BackgroundSelf-citationHTLV-1 induces a Th1-like state in CD4+CCR4+ T cells
Araya, N., Sato, T., Ando, H., Tomaru, U., Yoshida, M., Coler-Reilly, A., Yagishita, N., Yamauchi, J., Hasegawa, A., Kannagi, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75250 · Cited by 113
“Due to the high proportion of CCR4 positivity among HTLV-1–infected cells (19), the high proviral load in the CSF of HAM/TSP patients (47), and the elevated levels of CCL22 in HAM/TSP patient peripheral blood (30), one might hypothesize that the infected cells migrate across the blood-brain barrier…”
InfluentialSelf-citationRecent advances in the mechanisms of neuroinflammation and their roles in neurodegeneration
Niranjan, R. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.07.003 · Cited by 124
“The CD4+,CD25+ and Foxp3+ regulatory T cells (Tregs) are endogenous immune suppressors, and their role in neuroinflammation is important as they function in reducing T-cell proliferation and pro-inflammatory cytokine production (Reynolds et al., 2010; Rosenkranz et al., 2007; Yamano et al., 2009).”
BackgroundHTLV-1, Immune Response and Autoimmunity
Quaresma, J. A. S., Yoshikawa, G. T., Koyama, R. V. L., Dias, G., Fujihara, S., & Fuzii, H. T. (2015) · Viruses · doi:10.3390/v8010005 · Cited by 123
Sato, T., Coler-Reilly, A., Utsunomiya, A., Araya, N., Yagishita, N., Ando, H., Yamauchi, J., Inoue, E., Ueno, T., Hasegawa, Y., et al. (2013) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0002479 · Cited by 107
Self-citationPositive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy
Ando, H., Sato, T., Tomaru, U., Yoshida, M., Utsunomiya, A., Yamauchi, J., Araya, N., Yagishita, N., Coler-Reilly, A., Shimizu, Y., et al. (2013) · Brain · doi:10.1093/brain/awt183 · Cited by 104
“4B), and we previously demonstrated that HTLV-1-infected T cells in patients with HAM/TSP exhibit elevated IFN-g and reduced IL-17 production (Yamano et al., 2009).”
BackgroundMethodSelf-citationHTLV-1 bZIP Factor Induces Inflammation through Labile Foxp3 Expression
Yamamoto-Taguchi, N., Satou, Y., Miyazato, P., Ohshima, K., Nakagawa, M., Katagiri, K., Kinashi, T., & Matsuoka, M. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003630 · Cited by 88
Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP
Enose-Akahata, Y., Vellucci, A., & Jacobson, S. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02563 · Cited by 88
“HBZ suppresses the IFN-γ gene transcription through inhibition of AP-1 and NFAT while Tax activates the IFN-γ gene promoter (Sugata et al., 2012).”
BackgroundInfluentialSelf-citationYasuma-Mitobe, K., Yasunaga, J., Takemoto, K., Sugata, K., Mitobe, Y., Takenouchi, N., Nakagawa, M., Suzuki, Y., & Matsuoka, M. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005372 · Cited by 99
“In HTLV-1 infected individuals, the provirus is mainly present in CD4CCR4CADM1 T cells, indicating that this virus targets a certain subpopulation of T cells [7, 8].”
BackgroundHTLV-1 Viral Factor HBZ Induces CCR4 to Promote T-cell Migration and Proliferation
Sugata, K., Yasunaga, J., Kinosada, H., Mitobe, Y., Furuta, R., Mahgoub, M., Onishi, C., Nakashima, K., Ohshima, K., & Matsuoka, M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0361 · Cited by 88
“It has been reported that IFN-γ production is increased in the HTLV-1 infected cells of HAM/TSP patients (7).”
BackgroundInfluentialHuman T-cell leukemia virus type 1 infects multiple lineage hematopoietic cells in vivo
Furuta, R., Yasunaga, J.-I., Miura, M., Sugata, K., Saito, A., Akari, H., Ueno, T., Takenouchi, N., Fujisawa, J.-I., Koh, K.-R., et al. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006722 · Cited by 83
Human T-cell leukaemia virus type 1: parasitism and pathogenesis
Bangham, C. R. M., & Matsuoka, M. (2017) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2016.0272 · Cited by 88
An animal model of adult T-cell leukemia: humanized mice with HTLV-1–specific immunity
Tezuka, K., Xun, R., Tei, M., Ueno, T., Tanaka, M., Takenouchi, N., & Fujisawa, J.-I. (2014) · Blood · doi:10.1182/blood-2013-06-508861 · Cited by 68
Sato, T., Yagishita, N., Tamaki, K., Inoue, E., Hasegawa, D., Nagasaka, M., Suzuki, H., Araya, N., Coler-Reilly, A., Hasegawa, Y., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01651 · Cited by 68
Self-citationAraya, N., Takahashi, K., Sato, T., Nakamura, T., Sawa, C., Hasegawa, D., Ando, H., Aratani, S., Yagishita, N., Fujii, R., et al. (2010) · Antiviral Therapy · doi:10.3851/imp1699 · Cited by 72
“Although the mechanism responsible for the decreased viral load by interferon-α is still not clear, prosultiamine and green tea extract induce apoptosis of HTLV-1-infected cells [29,34].”
BackgroundSelf-citationYamauchi, J., Araya, N., Yagishita, N., Sato, T., & Yamano, Y. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107669 · Cited by 69
Self-citationManivannan, K., Rowan, A. G., Tanaka, Y., Taylor, G. P., & Bangham, C. R. M. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005560 · Cited by 64
“proposed the use of CD25 alone or in combination with CCR4 to isolate infected cells [20,27].”
BackgroundMethodAraya, N., Sato, T., Yagishita, N., Ando, H., Utsunomiya, A., Jacobson, S., & Yamano, Y. (2011) · Viruses · doi:10.3390/v3091532 · Cited by 69
“demonstrated that CD4CD25 T cells in HAM/TSP patients exhibit reduced Foxp3 expression and Treg suppression [30–33] and that HTLV-1-infected CD4 T cells in HAM/TSP patients produce Th1 cytokines (IFN-γ) [16,30], it has also been observed that CCR4 selectively overexpresses on HTLV-1-infected T cells in HAM/TSP patient…”
BackgroundInfluentialSelf-citationNeuroimmunity of HTLV-I Infection
Matsuura, E., Yamano, Y., & Jacobson, S. (2010) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-010-9216-9 · Cited by 65
“Recently, Yamano et al. reported the CD4+ CD25+ CCR4+ T cell subset was increased in HAM/TSP patients and also highly infected with HTLV-I compared with CD4+ CD25+ CCR4− cells (Yamano et al. 2009).”
Self-citationYamano, Y., & Coler-Reilly, A. L. G. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.08.012 · Cited by 60
“…the effects of HTLV-1 infection on the functioning of Th cells, we investigated how these individual subsets are targeted by HTLV-1 in HAM/ TSP. Recently, we showed that CD4+ cells that have the CCR4 receptor are much more likely to be infected by HTLV-1 (Yamano et al., 2009; Araya et al., 2014).”
BackgroundInfluentialSelf-citationImmunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP)
Fuzii, H. T., Dias, G. A. D. S., de Barros, R. J. S., Falcão, L. F. M., & Quaresma, J. A. S. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.03.025 · Cited by 65
“1) and the CNS, leading to inflammation of the nervous tissue (Morgan, 2011; Ahuja et al., 2007; Yamano et al., 2009).”
BackgroundInfluentialNozuma, S., & Jacobson, S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00885 · Cited by 59
“HTLV-1 Tax-specific CD8+ T-cells expressed high IL-15Rα (Azimi et al., 2001) and induced degranulation and IFN-γ expression when stimulated by IL-15 (Enose-Akahata et al., 2008).”
BackgroundSelf-citationMiura, M., Yasunaga, J.-I., Tanabe, J., Sugata, K., Zhao, T., Ma, G., Miyazato, P., Ohshima, K., Kaneko, A., Watanabe, A., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-118 · Cited by 50
“HTLV-1-infected cells of healthy carriers also express CCR4, which indicates that mogamulizumab likely reduces the proviral load in HTLV-1-infected asymptomatic individuals [30].”
BackgroundImmunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
Enose-Akahata, Y., & Jacobson, S. (2019) · Retrovirology · doi:10.1186/s12977-019-0499-5 · Cited by 49
Self-citationKchour, G., Rezaee, S. A., Farid, R., Ghantous, A., Rafatpanah, H., Tarhini, M., Kooshyar, M. M., Hajj, H. E., Berry, F., Mortada, M., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-91 · Cited by 56
Pathogenesis of HTLV-1 infection and progression biomarkers: An overview
Brites, C. R., Grassi, M. F. R., Quaresma, J. A. S., Ishak, R., & Vallinoto, A. C. R. (2021) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2021.101594 · Cited by 59
Satou, Y., & Matsuoka, M. (2010) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.50.1 · Cited by 54
Baratella, M., Forlani, G., Raval, G. U., Tedeschi, A., Gout, O., Gessain, A., Tosi, G., & Accolla, R. S. (2017) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0005285 · Cited by 42
Yamauchi, J., Coler-Reilly, A., Sato, T., Araya, N., Yagishita, N., Ando, H., Kunitomo, Y., Takahashi, K., Tanaka, Y., Shibagaki, Y., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiu438 · Cited by 41
Self-citationNozuma, S., Kubota, R., & Jacobson, S. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00881-w · Cited by 49
“In HAM/TSP patients, the frequency of IFN-γ-producing CD4CD25CCR4 T cells is increased and correlated with disease activity and severity (Yamano et al. 2009).”
BackgroundSelf-citationThe Role of Chemokines in the Pathogenesis of HTLV-1
Zargari, R., Mahdifar, M., Mohammadi, A., Vahidi, Z., Hassanshahi, G., & Rafatpanah, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00421 · Cited by 37
Mitagami, Y., Yasunaga, J., Kinosada, H., Ohshima, K., & Matsuoka, M. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005120 · Cited by 54
“In HAM/TSP patients, IFN-γ-producing cells are increased in a CD4FoxP3 subpopulation, and suggested to have a role in the pathogenesis of this inflammatory disease [48, 49].”
BackgroundImmunophenotypic characterization of CSF B cells in virus-associated neuroinflammatory diseases
Enose‐Akahata, Y., Azodi, S., Smith, B., Billioux, B. J., Vellucci, A., Ngouth, N., Tanaka, Y., Ohayon, J. M., Cortese, I. C. M., Nath, A., et al. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007042 · Cited by 38
Self-citationLeal, F. E., Ndhlovu, L. C., Hasenkrug, A. M., Bruno, F. R., Carvalho, K. I., Wynn-Williams, H., Neto, W. K., Sanabani, S. S., Segurado, A. A. C., Nixon, D. F., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002028 · Cited by 41
“IL-17 also plays a pivotal role in the pathogenesis of HIV infection [50,82] and various inflammatory diseases [83], but conflicting results regarding frequency of Th17 and IL-17 production were described in HTLV-1 infection [43,44].”
BackgroundResultInfluentialCytokine Therapies in Neurological Disease
Azodi, S., & Jacobson, S. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0455-1 · Cited by 39
Self-citationKagdi, H., Demontis, M. A., Ramos, J. C., & Taylor, G. P. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1006861 · Cited by 35
HTLV-1 Infection and Rheumatic Diseases
Umekita, K., & Okayama, A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00152 · Cited by 36
“In addition, HTLV-1 Tax was shown to activate the t-bet gene with reduced expression of FoxP3 in the infected cells, resulting in their differentiation toward Th1 in HAM/TSP (Yamano et al., 2009; Yamamoto-Taguchi et al., 2013; Araya et al., 2014).”
BackgroundMenezes, S. M., Decanine, D., Brassat, D., Khouri, R., Schnitman, S. V., Kruschewsky, R. D. A., López, G., Álvarez, C., Talledo, M., Gotuzzo, E., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-18 · Cited by 40
Mitagami, Y., Yasunaga, J., Kinosada, H., Ohshima, K., & Matsuoka, M. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005214 · Cited by 31
Ouaguia, L., Mrizak, D., Renaud, S., Moralès, O., & Delhem, N. (2014) · Mediators of Inflammation · doi:10.1155/2014/564296 · Cited by 36
Wolf, S. N., Haddow, J., Greiller, C. L., Taylor, G. P., Cook, L. B. M., & Rowan, A. G. (2021) · Blood Cancer Journal · doi:10.1038/s41408-021-00458-8 · Cited by 39
Current Perspectives in Human T-Cell Leukemia Virus Type 1 Infection and Its Associated Diseases
Miura, M., Naito, T., & Saito, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.867478 · Cited by 34
“CCR4 is a chemokine receptor highly expressed in ATL (42) and HAM/TSP (43).”
BackgroundEpigenetic Modification of the FoxP3 TSDR in HAM/TSP Decreases the Functional Suppression of Tregs
Anderson, M. R., Enose‐Akahata, Y., Massoud, R., Ngouth, N., Tanaka, Y., Oh, U., & Jacobson, S. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9547-z · Cited by 31
“These results are likely due to transient expression of FoxP3 in activated T cells, which are increased in HAM/TSP patients compared to NDs (Yamano et al. 2009).”
Self-citationOhsugi, T., & Kumasaka, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018518 · Cited by 28
“cells, is increased in patients with HAM/TSP, with greater proportions observed among patients with more severe disease”
BackgroundEnhancement of anti-STLV-1/HTLV-1 immune responses through multimodal effects of anti-CCR4 antibody
Sugata, K., Yasunaga, J., Miura, M., Akari, H., Utsunomiya, A., Nosaka, K., Watanabe, Y., Suzushima, H., Koh, K., Nakagawa, M., et al. (2016) · Scientific Reports · doi:10.1038/srep27150 · Cited by 26
Self-citationForlani, G., Baratella, M., Tedeschi, A., Pique, C., Jacobson, S., & Accolla, R. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00819 · Cited by 30
Self-citationNK cells and monocytes modulate primary HTLV-1 infection
Moles, R., Sarkis, S., Galli, V., Omsland, M., Artesi, M., Bissa, M., McKinnon, K. M., Brown, S., Hahaut, V., Washington‐Parks, R., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010416 · Cited by 28
Risk stratification of adult T‐cell leukemia/lymphoma using immunophenotyping
Kagdi, H., Demontis, M. A., Fields, P. A., Ramos, J. C., Bangham, C. R. M., & Taylor, G. P. (2016) · Cancer Medicine · doi:10.1002/cam4.928 · Cited by 27
“Both CCR4+ [16, 26] and CD26− immunophenotype [18] have been shown previously to be associated with both nonATL and ATL HTLV1 infection.”
BackgroundHAM/TSP Pathogenesis: The Transmigration Activity of HTLV-1-Infected T Cells into Tissues
Nakamura, T. (2023) · Pathogens · doi:10.3390/pathogens12030492 · Cited by 31
“in PBMC was correlated with disease activity of HAM/TSP [10].”
Espíndola, O. D. M., Oliveira, L. C., Ferreira, P. M., Leite, A. C. C. B., Lima, M. A., & Andrada‐Serpa, M. J. (2015) · Intervirology · doi:10.1159/000371766 · Cited by 27
Clinical trial of raltegravir, an integrase inhibitor, in HAM/TSP
Enose‐Akahata, Y., Billioux, B. J., Azodi, S., Dwyer, J. E., Vellucci, A., Ngouth, N., Nozuma, S., Massoud, R., Cortese, I. C. M., Ohayon, J. M., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51437 · Cited by 24
“This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. stable within each subject, a higher…”
BackgroundResultInfluentialSelf-citationNeco, H. V. P. D. C., Teixeira, V. G. D. S., da Trindade, A. C. L., Magalhães, P. M. R., de Lorena, V. M. B., Castellano, L. R. C., de Souza, J. R., Vasconcelos, L. R. S., de Moura, P. M. M. F., & de Morais, C. N. L. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2016.0296 · Cited by 24
Current State of Therapeutics for HTLV-1
Wang, T. T., Hirons, A., Doerflinger, M., Morris, K. V., Ledger, S., Purcell, D. F. J., Kelleher, A. D., & Ahlenstiel, C. L. (2024) · Viruses · doi:10.3390/v16101616 · Cited by 22
“Treatments for HTLV-1-associated diseases and infection.”
Sato, T., Nagai, M., Watanabe, O., Misu, T., Takenouchi, N., Ohkubo, R., Ishihara, S., Tsuboi, Y., Katsuno, M., Nakagawa, M., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12239-x · Cited by 21
Self-citationAssone, T., Menezes, S. M., Gonçalves, F. D. T., Folgosi, V. Â., Prates, G. D. S., Dierckx, T., Braz, M., Smid, J., Haziot, M. E., Marcusso, R. M. N., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02658-w · Cited by 27
Complex role of microRNAs in HTLV-1 infections
Sampey, G. C., Duyne, R. V., Currer, R., Das, R., Narayanan, A., & Kashanchi, F. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00295 · Cited by 27
Saito, M., Tanaka, R., Fujii, H., Kodama, A., Takahashi, Y., Matsuzaki, T., Takashima, H., & Tanaka, Y. (2014) · Retrovirology · doi:10.1186/s12977-014-0074-z · Cited by 24
“Furthermore, these Tax-expressing CD4-positive cells were more frequently positive for chemokine (C-C motif ) receptor 4 (CCR4) than Tax-negative CD4-positive cells (Figure 2B), as previously reported in natural HTLV-1 infections [17,18].”
BackgroundQueiroz, M. A. F., Azevedo, V. N., Amoras, E. D. S. G., Moura, T. C. F., Ishak, M. D. O. G., Ishak, R., Vallinoto, A. C. R., & Feitosa, R. N. M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00795 · Cited by 19
“Elevated IFN-γ levels in patients with HAM/TSP have previously been associated with central nervous system inflammatory disorders (Yamano et al., 2009).”
BackgroundRafatpanah, H., Hosseini, R. F., & Pourseyed, S. H. (2013) · PubMed Central · Cited by 20
Clinical trial of a humanized anti‐IL‐2/IL‐15 receptor β chain in HAM/TSP
Enose‐Akahata, Y., Oh, U., Ohayon, J. M., Billioux, B. J., Massoud, R., Bryant, B. R., Vellucci, A., Ngouth, N., Cortese, I. C. M., Waldmann, T. A., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50820 · Cited by 20
Self-citationKoseki, A., Araya, N., Yamagishi, M., Yamauchi, J., Yagishita, N., Takao, N., Takahashi, K., Kunitomo, Y., Honma, D., Araki, K., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1175762 · Cited by 16
Self-citationEffect of HTLV-1 Infection on the Clinical Course of Patients with Rheumatoid Arthritis
Umekita, K. (2022) · Viruses · doi:10.3390/v14071460 · Cited by 18
Levin, M. C., Lee, Gardner, Shin, Douglas, & Groover (2012) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s38353 · Cited by 18
Perfil clínico-epidemiológico de pacientes infectados pelo HTLV-1 em Belém/Pará
Glória, L. M., Damasceno, S. D. A., Rodrigues, L. R., dos Santos, M. D. S. B., Medeiros, R., Dias, G. A. D. S., & Pinto, D. D. S. (2015) · Cadernos Saúde Coletiva · doi:10.1590/1414-462x201400050087 · Cited by 17
Correlation between clinical symptoms and peripheral immune response in HAM/TSP
Dias, G. A. D. S., Sousa, R. C. M., Gomes, L. F., Caldas, C. A. M., Nassiri, R., Quaresma, J. A. S., & Fuzii, H. T. (2015) · Microbial Pathogenesis · doi:10.1016/j.micpath.2015.11.018 · Cited by 15
Aghajanian, S., Teymoori‐Rad, M., Molaverdi, G., & Mozhgani, S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.614940 · Cited by 16
“Nevertheless, CD4+CD25+CCR4+ T-cell population have been noted to be prime viral reservoirs of the virus in both ATLL and HAM/TSP patients (Yamano et al., 2004, 2009).”
BackgroundPreapoptotic protease calpain-2 is frequently suppressed in adult T-cell leukemia
Ishihara, M., Araya, N., Sato, T., Tatsuguchi, A., Saichi, N., Utsunomiya, A., Nakamura, Y., Nakagawa, H., Yamano, Y., & Ueda, K. (2013) · Blood · doi:10.1182/blood-2012-08-446922 · Cited by 16
Self-citationMedina, F., Quintremil, S., Alberti, C., Godoy, F., Pando, M. E., Bustamante, A., Barriga, A., Cartier, L., Puente, J., Tanaka, Y., et al. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24342 · Cited by 16
“C 2015 WILEY PERIODICALS, INC. [Bangham, 2000; Nagai and Osame, 2003; Verdonck et al., 2007; Yamano et al., 2009].”
BackgroundPreferential gene transcription of T helper 2 cytokines in peripheral CCR4+CD4+ lymphocytes in dogs
Iio, A., Motohashi, T., Kunisada, T., Yasuhira, Y., Kamishina, H., & Maeda, S. (2014) · Veterinary Dermatology · doi:10.1111/vde.12125 · Cited by 12
Ghezeldasht, S. A., Mosavat, A., & Rezaee, S. A. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.2567 · Cited by 12
Cook, L. B. M., Demontis, M. A., Sagawe, S., Witkover, A., Melamed, A., Turpin, J., Dillon, R. J., Haddow, J., Marks, A. J., Bangham, C. R. M., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.219253 · Cited by 12
Espíndola, O. D. M., Rijnstra, E. S.-V., Frankin, E., Weijer, K. C., van der Velden, Y. U., Berkhout, B., Blom, B., & Villaudy, J. (2021) · Cells · doi:10.3390/cells10102514 · Cited by 13
“Indeed, it was shown that CD4+CCR4+ T-cells represent the main reservoir of HTLV-1-infected cells [66].”
InfluentialShafiei, M., & Mozhgani, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03303-0 · Cited by 13
Sarkis, S., Belrose, G., Péloponèse, J., Olindo, S., Césaire, R., Mesnard, J.-M., & Gross, A. (2013) · Journal of Clinical Virology · doi:10.1016/j.jcv.2013.05.006 · Cited by 14
Saeidi, M., Vahidi, Z., Nahayati, M., Khadem‐Rezaiyan, M., Zemorshidi, F., Mahdifar, M., Hafezi, F., Moghadam, S. M., Saghi, E., Akbarpour, E., et al. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105962 · Cited by 10
T cell receptor repertoire analysis in HTLV-1-associated diseases
Clauze, A., Enose‐Akahata, Y., & Jacobson, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.984274 · Cited by 12
“The clonal expansion of TCR-b clonotypes in CSF of HAM/TSP patients has been suggested to be associated with high numbers of activated CD4 T cells and CD8 T cells found in CSF of HAM/TSP patients (34, 35, 65, 66).”
BackgroundSelf-citationNicolete, L. D. D. F., Nicolete, R., Haddad, R., Azevedo, R., de Castro, F. A., Tanaka, Y., Takayanagui, O. M., Covas, D. T., & Kashima, S. H. (2012) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762012000600020 · Cited by 9
Hiyoshi, M., Okuma, K., Tateyama, S., Takizawa, K., Saito, M., Kuramitsu, M., Araki, K., Morishita, K., Okada, S., Yamamoto, N., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0199-8 · Cited by 10
“Recent studies have demonstrated that CCR4 is frequently expressed in HTLV-1-infected cells, which are predominantly CD4+CD25+ [18–21].”
Pathogenesis of human T‐lymphotropic virus type 1‐associated myelopathy/tropical spastic paraparesis
Kubota, R. (2017) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12395 · Cited by 11
“T cells commonly have a Th2 phenotype and secrete IL-4; however, CD4+ CD25+ FoxP3+ HTLV-1infected cells secrete IFN-c on stimulation, suggesting a Th1-like phenotype.(30,31)”
BackgroundHashiba, Y., Umekita, K., Kimura, M., Iwao, C., Iwao, K., Kariya, Y., Kubo, K., Miyauchi, S., Kudou, R., Rikitake, Y., et al. (2021) · Modern Rheumatology · doi:10.1093/mr/roab077 · Cited by 7
“Other reports have demonstrated that peripheral blood mononuclear cells (PBMCs) isolated from HTLV-1-infected individuals autonomously produce interferon-γ (IFN-γ) in cell culture conditions [13, 14].”
BackgroundKitazono, T., Okazaki, T., Araya, N., Yamano, Y., Yamada, Y., Nakamura, T., Tanaka, Y., Inoue, M., & Ozaki, S. (2011) · Cellular Immunology · doi:10.1016/j.cellimm.2011.10.002 · Cited by 7
Self-citationUmekita, K., Hashiba, Y., Iwao, K., Iwao, C., Kimura, M., Kariya, Y., Kubo, K., Miyauchi, S., Kudou, R., Rikitake, Y., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233159 · Cited by 9
Talukder, M. R., Walley, R., Pham, H. D., Schinke, S., Woodman, R. J., Wilson, K. M., Sajiv, C., & Einsiedel, L. J. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25532 · Cited by 9
Joseph, J., Premeaux, T. A., Pinto, D. O., Rao, A. S., Guha, S., Panfil, A. R., Carey, A. J., Ndhlovu, L. C., Bergmann‐Leitner, E. S., & Jain, P. (2023) · Journal of Extracellular Biology · doi:10.1002/jex2.102 · Cited by 6
“In metastatic melanoma, there is a high release of exosomes carrying PD-L1 on their surface, resulting in increased tumour growth and the suppression of tumour-specific CD8 + T cells (Araya et al., 2014; Yamano et al., 2009).”
BackgroundAraya, N., Sato, T., Coler-Reilly, A. L. G., Yagishita, N., & Yamano, Y. (2016) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.39.207 · Cited by 6
Self-citationGois, L. L., Soares, B. N. R. R., Regis-Silva, C. G., Zanette, D. L., Lisboa, R., Nascimento, R. S., Coutinho, R., Galvão‐Castro, B., & Grassi, M. F. R. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09494-8 · Cited by 5
Ahmed, B., Aliyu, M., Getso, M. I., Bala, J. A., Ahmed, R. J., Kabuga, A. I., Adamu, A.-M. Y., & Yusuf, A. A. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104614 · Cited by 4
Gutowska, A., Sarkis, S., Rahman, M. A., Goldfarbmuren, K. C., Moles, R., Bissa, M., Doster, M. N., Washington‐Parks, R., McKinnon, K. M., de Castro, I. S., et al. (2024) · Pathogens · doi:10.3390/pathogens13040292 · Cited by 4
Yamada, R., Arima, K., Yano, H., Fujiwara, Y., Yamashita, K., Kanemitsu, K., Hanada, N., Yasunaga, J., Iwatsuki, M., Mikami, Y., et al. (2025) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-025-04074-w · Cited by 7
“Recent studies have suggested that the immunosuppressive function of Tregs is impaired by HTLV-1 infection, triggering an inflammatory response and leading to inflammatory conditions such as HAM [8, 9].”
Shafiei, M., Ghadimi, S., Baharlou, P., Moghimi, F., Letafati, A., & Mozhgani, S. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156710 · Cited by 4
Shafiei, M., Ardalan, N., Letafati, A., Nia, M. M. K., Bahavar, A., Shahnavaz, V., & Mozhgani, S. (2025) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2025.2575368 · Cited by 4
“Yamano et al. [39] observed a growing number of functionally and phenotypically altered HTLV-1 CD4+CD25+CCR4+ infected T cells, the primary reservoir of the virus, during HAM/TSP. Yamano stated that these unique T cell subpopulations (called T HAM ) become Th1-like cells characterized by…”
Interferon dynamics in deltaretroviruses: why HTLV-1 evades, but BLV responds
Akbarin, M. M., Farjami, Z., & Álvarez, H. R. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-11749-3 · Cited by 3
“Similarly, Yamano et al. (2009) identified highly pro-inflammatory IFN-γ⁺ CCR4⁺ CD4⁺ CD25⁺ infected T cells that contribute to chronic inflammation while serving as viral reservoirs [75 ].”
Júnior, R. D. S. R., Gomes, J. A. N., Dias, G. A. D. S., Fujihara, S., Yoshikawa, G. T., Koyama, R. V. L., Sousa, R. C. M., Quaresma, J. A. S., & Fuzii, H. T. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152740 · Cited by 2
Factors Influencing the Indeterminate Results in a T-SPOT.TB test: A Matched Case-control Study
Herai, Y., Yahaba, M., Taniguchi, T., Murata, S., Chiba, H., & Igari, H. (2023) · Internal Medicine · doi:10.2169/internalmedicine.1006-22 · Cited by 2
“(25-29).”
The contribution of Asian researchers to the field of rheumatology
Yamano, Y., & Nishioka, K. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.257 · Cited by 2
“and in those with HTLV-1-associated neuroimmunological disorders”
Self-citationGhazvini, K., Youssefi, M., & Keikha, M. (2020) · Access Microbiology · doi:10.1099/acmi.0.000088 · Cited by 2
“Gradually, the IFN-γ produced CD4+CD25+CCR4+-infected T cells stimulate transcription factor T- bet activity and lead to Th1 induction and ultimately produce large amounts of IFN-γ as well as inflammation of the CNS [17, 18].”
BackgroundBurbano, Y. C. B., Paz, A. V. C., Caldon, C. C. R., Constain, J. S. R., Gonzáles, G. I. Á., Hernández, J. C. K., Marín, N. D., Dueñas-Cuellar, R. A., & Niño-Castaño, V. E. (2019) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0101-2019 · Cited by 2
Metadata
- Authors
- Yamano, Y., Araya, N., Sato, T., Utsunomiya, A., Azakami, K., Hasegawa, D., Izumi, T., Fujita, H., Aratani, S., Yagishita, N., Fujii, R., Nishioka, K., Jacobson, S., & Nakajima, T.
- Affiliations
- St. Marianna University School of Medicine (JP)
- Imamura Hospital (JP)
- National Institutes of Health (US)
- Corresponding author
- Yamano, Yoshihisa
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-08-05
- Volume
- 4
- Issue
- 8
- Pages
- e6517
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2715877
- OpenAlex
- W2123524329
- Cited by
- 140
- References
- 48
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 12 · 2023: 6 · 2022: 7 · 2021: 6 · 2020: 8 · 2019: 9 · 2018: 6 · 2017: 9 · 2016: 10 · 2015: 11 · 2014: 10 · 2013: 11 · 2012: 7
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Uehara Memorial Foundation
- Ministry of Education, Culture, Sports, Science and Technology
- National Institute of Biomedical Innovation
- Mishima Kaiun Memorial Foundation
- Japan Society for the Promotion of Science (20249052)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- HTLV-1, HAM/TSP, adult T-cell leukemia/lymphoma, CCR4, CD4+CD25+ T cells, regulatory T cells, Foxp3, interferon-gamma, neuroinflammation, viral reservoir, Th17 cells, Th2 cells, IL-17, IL-10, IL-4, disease activity
- MeSH terms
- Interferon-gamma, Nervous System Diseases, T-Lymphocytes, Human T-lymphotropic virus 1, HTLV-I Infections, CD4 Antigens, Interleukin-4, Case-Control Studies, Interleukin-10, Cell Proliferation, Interleukin-2 Receptor alpha Subunit, Receptors, CCR4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.